BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17579804)

  • 1. Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France.
    Debouverie M; Louis S; Pittion-Vouyovitch S; Roederer T; Vespignani H
    J Neurol; 2007 Oct; 254(10):1370-5. PubMed ID: 17579804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
    Debouverie M
    J Neurol Sci; 2009 Nov; 286(1-2):14-7. PubMed ID: 19691994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of multiple sclerosis in a population-based cohort.
    Debouverie M; Pittion-Vouyovitch S; Louis S; Guillemin F;
    Eur J Neurol; 2008 Sep; 15(9):916-21. PubMed ID: 18637953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability.
    Andersson PB; Waubant E; Gee L; Goodkin DE
    Arch Neurol; 1999 Sep; 56(9):1138-42. PubMed ID: 10488816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
    Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
    J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability progression in multiple sclerosis: a Tunisian prospective cohort study.
    Hentati E; Ben Sassi S; Nabli F; Mabrouk T; Zouari M; Hentati F
    Neurol Sci; 2018 May; 39(5):879-884. PubMed ID: 29476286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of early versus late disability accumulation in primary progressive MS.
    Koch MW; Greenfield J; Javizian O; Deighton S; Wall W; Metz LM
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):615-21. PubMed ID: 25091366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
    Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC
    Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapses and progression of disability in multiple sclerosis.
    Confavreux C; Vukusic S; Moreau T; Adeleine P
    N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostics factors of renal failure in multiple sclerosis].
    Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
    Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France.
    Debouverie M; Pittion-Vouyovitch S; Louis S; Roederer T; Guillemin F
    Mult Scler; 2007 Sep; 13(8):962-7. PubMed ID: 17623734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and disability accumulation in multiple sclerosis.
    Scalfari A; Neuhaus A; Daumer M; Ebers GC; Muraro PA
    Neurology; 2011 Sep; 77(13):1246-52. PubMed ID: 21917763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of primary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H
    Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; De Keyser J
    Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.
    Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van der Walt A; Butzkueven H; Kalincik T;
    JAMA Neurol; 2018 Nov; 75(11):1407-1415. PubMed ID: 30083762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported levels of education and disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Van Remoortel A; De Keyser J; Nagels G
    Acta Neurol Scand; 2016 Dec; 134(6):414-419. PubMed ID: 27761897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.